14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for BCAB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.32 28.28 %
R2 3.84 13.89 %
R1 3.54 5.00 %
Current price: 3.37
Support S1 2.57 -23.79 %
S2 2.27 -32.69 %
S3 1.78 -47.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.92 16.32 %
R2 3.70 9.79 %
R1 3.46 2.67 %
Current price 3.37
Support S1 3.01 -10.68%
S2 2.84 -15.73%
S3 2.77 -17.80%

BCAB Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About BioAtla, Inc.

BioAtla. BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, mel... BCAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT